APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Microbial Source Hydrocolloids

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Microbial Source Hydrocolloids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174560340313 August 2026196 pages

Choose your research edition.

Industry ResearchMicrobial Source Hydrocolloids Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbial Source Hydrocolloids Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Microbial Source Hydrocolloids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbial Source Hydrocolloids Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Microbial Source Hydrocolloids Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Microbial Source Hydrocolloids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Microbial Source Hydrocolloids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microbial Source Hydrocolloids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbial Source Hydrocolloids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Microbial Source Hydrocolloids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Microbial Source Hydrocolloids include CEAMSA, Hispanagar SA, CP Kelco, DuPont, Cargill, Ingredion, Archer Daniels Midland, Koninklijke DSM and Ashland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Microbial Source Hydrocolloids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microbial Source Hydrocolloids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microbial Source Hydrocolloids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Microbial Source Hydrocolloids market size, projected growth trends, production technologies, key applications, and end-use industries.

Microbial Source Hydrocolloids Segment by Company

CEAMSA

Hispanagar SA

CP Kelco

DuPont

Cargill

Ingredion

Archer Daniels Midland

Koninklijke DSM

Ashland

Fuerst Day Lawson

Nestle

Jungbunzlauer

Deosen Biochemical

Tate & Lyle

Lubrizol

Fiberstar

B&V SRL

Hawkins Watts

Microbial Source Hydrocolloids Segment by Type

Xanthan Gum

Curdlan

Gellan Gum

Others

Microbial Source Hydrocolloids Segment by Application

Bakery and Confectionery

Dairy

Beverages

Meat & Poultry

Others

Microbial Source Hydrocolloids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Source Hydrocolloids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbial Source Hydrocolloids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Source Hydrocolloids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Microbial Source Hydrocolloids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Microbial Source Hydrocolloids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Microbial Source Hydrocolloids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Microbial Source Hydrocolloids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Microbial Source Hydrocolloids Industry Trends Table 2. Microbial Source Hydrocolloids Industry Drivers Table 3. Microbial Source Hydrocolloids Industry Opportunities and Challenges Table 4. Microbial Source Hydrocolloids Industry Restraints Table 5. Global Microbial Source Hydrocolloids Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Microbial Source Hydrocolloids Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Microbial Source Hydrocolloids Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Microbial Source Hydrocolloids Sales Market Share by Manufacturers Table 9. Global Microbial Source Hydrocolloids Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Microbial Source Hydrocolloids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Microbial Source Hydrocolloids Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Microbial Source Hydrocolloids Manufacturers, Product Type & Application Table 13. Global Microbial Source Hydrocolloids Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Microbial Source Hydrocolloids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Xanthan Gum Table 17. Major Manufacturers of Curdlan Table 18. Major Manufacturers of Gellan Gum Table 19. Major Manufacturers of Others Table 20. Global Microbial Source Hydrocolloids Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Microbial Source Hydrocolloids Sales by Type (2021-2026) & (k units) Table 22. Global Microbial Source Hydrocolloids Sales by Type (2027-2032) & (k units) Table 23. Global Microbial Source Hydrocolloids Sales Market Share by Type (2021-2026) Table 24. Global Microbial Source Hydrocolloids Sales Market Share by Type (2027-2032) Table 25. Global Microbial Source Hydrocolloids Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Microbial Source Hydrocolloids Revenue by Type (2021-2026) & (k units) Table 27. Global Microbial Source Hydrocolloids Revenue by Type (2027-2032) & (k units) Table 28. Global Microbial Source Hydrocolloids Revenue Market Share by Type (2021-2026) Table 29. Global Microbial Source Hydrocolloids Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Bakery and Confectionery Table 31. Major Manufacturers of Dairy Table 32. Major Manufacturers of Beverages Table 33. Major Manufacturers of Meat & Poultry Table 34. Major Manufacturers of Others Table 35. Global Microbial Source Hydrocolloids Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Microbial Source Hydrocolloids Sales by Application (2021-2026) & (k units) Table 37. Global Microbial Source Hydrocolloids Sales by Application (2027-2032) & (k units) Table 38. Global Microbial Source Hydrocolloids Sales Market Share by Application (2021-2026) Table 39. Global Microbial Source Hydrocolloids Sales Market Share by Application (2027-2032) Table 40. Global Microbial Source Hydrocolloids Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Microbial Source Hydrocolloids Revenue by Application (2021-2026) & (k units) Table 42. Global Microbial Source Hydrocolloids Revenue by Application (2027-2032) & (k units) Table 43. Global Microbial Source Hydrocolloids Revenue Market Share by Application (2021-2026) Table 44. Global Microbial Source Hydrocolloids Revenue Market Share by Application (2027-2032) Table 45. Global Microbial Source Hydrocolloids Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Microbial Source Hydrocolloids Sales by Region (2021-2026) & (k units) Table 47. Global Microbial Source Hydrocolloids Sales Market Share by Region (2021-2026) Table 48. Global Microbial Source Hydrocolloids Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Microbial Source Hydrocolloids Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Microbial Source Hydrocolloids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 52. North America Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 53. Europe Microbial Source Hydrocolloids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 55. Europe Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Microbial Source Hydrocolloids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Microbial Source Hydrocolloids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Microbial Source Hydrocolloids Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Microbial Source Hydrocolloids Sales by Country (2027-2032) & (k units) Table 62. Global Microbial Source Hydrocolloids Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Microbial Source Hydrocolloids Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Microbial Source Hydrocolloids Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Microbial Source Hydrocolloids Revenue Market Share by Region (2021-2026) Table 66. Global Microbial Source Hydrocolloids Revenue Market Share by Region (2027-2032) Table 67. CEAMSA Company Information Table 68. CEAMSA Business Overview Table 69. CEAMSA Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. CEAMSA Microbial Source Hydrocolloids Product Portfolio Table 71. CEAMSA Recent Development Table 72. Hispanagar SA Company Information Table 73. Hispanagar SA Business Overview Table 74. Hispanagar SA Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hispanagar SA Microbial Source Hydrocolloids Product Portfolio Table 76. Hispanagar SA Recent Development Table 77. CP Kelco Company Information Table 78. CP Kelco Business Overview Table 79. CP Kelco Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. CP Kelco Microbial Source Hydrocolloids Product Portfolio Table 81. CP Kelco Recent Development Table 82. DuPont Company Information Table 83. DuPont Business Overview Table 84. DuPont Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. DuPont Microbial Source Hydrocolloids Product Portfolio Table 86. DuPont Recent Development Table 87. Cargill Company Information Table 88. Cargill Business Overview Table 89. Cargill Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Cargill Microbial Source Hydrocolloids Product Portfolio Table 91. Cargill Recent Development Table 92. Ingredion Company Information Table 93. Ingredion Business Overview Table 94. Ingredion Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Ingredion Microbial Source Hydrocolloids Product Portfolio Table 96. Ingredion Recent Development Table 97. Archer Daniels Midland Company Information Table 98. Archer Daniels Midland Business Overview Table 99. Archer Daniels Midland Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Archer Daniels Midland Microbial Source Hydrocolloids Product Portfolio Table 101. Archer Daniels Midland Recent Development Table 102. Koninklijke DSM Company Information Table 103. Koninklijke DSM Business Overview Table 104. Koninklijke DSM Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Koninklijke DSM Microbial Source Hydrocolloids Product Portfolio Table 106. Koninklijke DSM Recent Development Table 107. Ashland Company Information Table 108. Ashland Business Overview Table 109. Ashland Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ashland Microbial Source Hydrocolloids Product Portfolio Table 111. Ashland Recent Development Table 112. Fuerst Day Lawson Company Information Table 113. Fuerst Day Lawson Business Overview Table 114. Fuerst Day Lawson Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Fuerst Day Lawson Microbial Source Hydrocolloids Product Portfolio Table 116. Fuerst Day Lawson Recent Development Table 117. Nestle Company Information Table 118. Nestle Business Overview Table 119. Nestle Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Nestle Microbial Source Hydrocolloids Product Portfolio Table 121. Nestle Recent Development Table 122. Jungbunzlauer Company Information Table 123. Jungbunzlauer Business Overview Table 124. Jungbunzlauer Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Jungbunzlauer Microbial Source Hydrocolloids Product Portfolio Table 126. Jungbunzlauer Recent Development Table 127. Deosen Biochemical Company Information Table 128. Deosen Biochemical Business Overview Table 129. Deosen Biochemical Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Deosen Biochemical Microbial Source Hydrocolloids Product Portfolio Table 131. Deosen Biochemical Recent Development Table 132. Tate & Lyle Company Information Table 133. Tate & Lyle Business Overview Table 134. Tate & Lyle Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Tate & Lyle Microbial Source Hydrocolloids Product Portfolio Table 136. Tate & Lyle Recent Development Table 137. Lubrizol Company Information Table 138. Lubrizol Business Overview Table 139. Lubrizol Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Lubrizol Microbial Source Hydrocolloids Product Portfolio Table 141. Lubrizol Recent Development Table 142. Fiberstar Company Information Table 143. Fiberstar Business Overview Table 144. Fiberstar Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Fiberstar Microbial Source Hydrocolloids Product Portfolio Table 146. Fiberstar Recent Development Table 147. B&V SRL Company Information Table 148. B&V SRL Business Overview Table 149. B&V SRL Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. B&V SRL Microbial Source Hydrocolloids Product Portfolio Table 151. B&V SRL Recent Development Table 152. Hawkins Watts Company Information Table 153. Hawkins Watts Business Overview Table 154. Hawkins Watts Microbial Source Hydrocolloids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Hawkins Watts Microbial Source Hydrocolloids Product Portfolio Table 156. Hawkins Watts Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Microbial Source Hydrocolloids Distributors List Table 160. Microbial Source Hydrocolloids Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Microbial Source Hydrocolloids Product Image Figure 2. Global Microbial Source Hydrocolloids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbial Source Hydrocolloids Market Size (2021-2032) & (US$ Million) Figure 4. Global Microbial Source Hydrocolloids Sales (2021-2032) & (k units) Figure 5. Global Microbial Source Hydrocolloids Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Microbial Source Hydrocolloids Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Xanthan Gum Image Figure 9. Curdlan Image Figure 10. Gellan Gum Image Figure 11. Others Image Figure 12. Global Microbial Source Hydrocolloids Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Microbial Source Hydrocolloids Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Microbial Source Hydrocolloids Sales Market Share by Type (2021-2032) Figure 15. Global Microbial Source Hydrocolloids Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Microbial Source Hydrocolloids Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Microbial Source Hydrocolloids Revenue Market Share by Type (2021-2032) Figure 18. Bakery and Confectionery Image Figure 19. Dairy Image Figure 20. Beverages Image Figure 21. Meat & Poultry Image Figure 22. Others Image Figure 23. Global Microbial Source Hydrocolloids Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Microbial Source Hydrocolloids Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Microbial Source Hydrocolloids Sales Market Share by Application (2021-2032) Figure 26. Global Microbial Source Hydrocolloids Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Microbial Source Hydrocolloids Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Microbial Source Hydrocolloids Revenue Market Share by Application (2021-2032) Figure 29. North America Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 31. U.S. Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 36. Germany Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 43. China Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Microbial Source Hydrocolloids Sales Market Share by Country (2021-2032) Figure 51. Brazil Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Microbial Source Hydrocolloids Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Microbial Source Hydrocolloids Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Microbial Source Hydrocolloids Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Microbial Source Hydrocolloids Revenue (2021-2032) & (US$ Million) Figure 62. North America Microbial Source Hydrocolloids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Microbial Source Hydrocolloids Revenue (2021-2032) & (US$ Million) Figure 64. Europe Microbial Source Hydrocolloids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Microbial Source Hydrocolloids Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Microbial Source Hydrocolloids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Microbial Source Hydrocolloids Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Microbial Source Hydrocolloids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Microbial Source Hydrocolloids Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Microbial Source Hydrocolloids Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Xanthan Gum
  • Curdlan
  • Gellan Gum
  • Others
Applications
  • Bakery and Confectionery
  • Dairy
  • Beverages
  • Meat & Poultry
  • Others
Companies covered
  • CEAMSA
  • Hispanagar SA
  • CP Kelco
  • DuPont
  • Cargill
  • Ingredion
  • Archer Daniels Midland
  • Koninklijke DSM
  • Ashland
  • Fuerst Day Lawson
  • Nestle
  • Jungbunzlauer
  • Deosen Biochemical
  • Tate & Lyle
  • Lubrizol
  • Fiberstar
  • B&V SRL
  • Hawkins Watts

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microbial Source Hydrocolloids Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microbial Source Hydrocolloids Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Microbial Source Hydrocolloids Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Microbial Source Hydrocolloids Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Microbial Source Hydrocolloids Market Dynamics
  1. 2.1 Microbial Source Hydrocolloids Industry Trends
  2. 2.2 Microbial Source Hydrocolloids Industry Drivers
  3. 2.3 Microbial Source Hydrocolloids Industry Opportunities and Challenges
  4. 2.4 Microbial Source Hydrocolloids Industry Restraints
3 Microbial Source Hydrocolloids Market by Manufacturers
  1. 3.1 Global Microbial Source Hydrocolloids Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Microbial Source Hydrocolloids Sales by Manufacturers (2021-2026)
  3. 3.3 Global Microbial Source Hydrocolloids Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Microbial Source Hydrocolloids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Microbial Source Hydrocolloids Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Microbial Source Hydrocolloids Manufacturers, Product Type & Application
  7. 3.7 Global Microbial Source Hydrocolloids Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Microbial Source Hydrocolloids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Microbial Source Hydrocolloids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Microbial Source Hydrocolloids Tier 1, Tier 2, and Tier 3
4 Microbial Source Hydrocolloids Market by Type
  1. 4.1 Microbial Source Hydrocolloids Type Introduction
  2. 4.1.1 Xanthan Gum
  3. 4.1.2 Curdlan
  4. 4.1.3 Gellan Gum
  5. 4.1.4 Others
  6. 4.2 Global Microbial Source Hydrocolloids Sales by Type
  7. 4.2.1 Global Microbial Source Hydrocolloids Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Microbial Source Hydrocolloids Sales by Type (2021-2032)
  9. 4.2.3 Global Microbial Source Hydrocolloids Sales Market Share by Type (2021-2032)
  10. 4.3 Global Microbial Source Hydrocolloids Revenue by Type
  11. 4.3.1 Global Microbial Source Hydrocolloids Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Microbial Source Hydrocolloids Revenue by Type (2021-2032)
  13. 4.3.3 Global Microbial Source Hydrocolloids Revenue Market Share by Type (2021-2032)
5 Microbial Source Hydrocolloids Market by Application
  1. 5.1 Microbial Source Hydrocolloids Application Introduction
  2. 5.1.1 Bakery and Confectionery
  3. 5.1.2 Dairy
  4. 5.1.3 Beverages
  5. 5.1.4 Meat & Poultry
  6. 5.1.5 Others
  7. 5.2 Global Microbial Source Hydrocolloids Sales by Application
  8. 5.2.1 Global Microbial Source Hydrocolloids Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Microbial Source Hydrocolloids Sales by Application (2021-2032)
  10. 5.2.3 Global Microbial Source Hydrocolloids Sales Market Share by Application (2021-2032)
  11. 5.3 Global Microbial Source Hydrocolloids Revenue by Application
  12. 5.3.1 Global Microbial Source Hydrocolloids Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Microbial Source Hydrocolloids Revenue by Application (2021-2032)
  14. 5.3.3 Global Microbial Source Hydrocolloids Revenue Market Share by Application (2021-2032)
6 Global Microbial Source Hydrocolloids Sales by Region
  1. 6.1 Global Microbial Source Hydrocolloids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microbial Source Hydrocolloids Sales by Region (2021-2032)
  3. 6.2.1 Global Microbial Source Hydrocolloids Sales by Region (2021-2026)
  4. 6.2.2 Global Microbial Source Hydrocolloids Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microbial Source Hydrocolloids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Microbial Source Hydrocolloids Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Microbial Source Hydrocolloids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Microbial Source Hydrocolloids Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Microbial Source Hydrocolloids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Microbial Source Hydrocolloids Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Microbial Source Hydrocolloids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Microbial Source Hydrocolloids Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Microbial Source Hydrocolloids Revenue by Region
  1. 7.1 Global Microbial Source Hydrocolloids Revenue by Region
  2. 7.1.1 Global Microbial Source Hydrocolloids Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Microbial Source Hydrocolloids Revenue by Region (2021-2026)
  4. 7.1.3 Global Microbial Source Hydrocolloids Revenue by Region (2027-2032)
  5. 7.1.4 Global Microbial Source Hydrocolloids Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Microbial Source Hydrocolloids Revenue (2021-2032)
  8. 7.2.2 North America Microbial Source Hydrocolloids Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Microbial Source Hydrocolloids Revenue (2021-2032)
  11. 7.3.2 Europe Microbial Source Hydrocolloids Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Microbial Source Hydrocolloids Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Microbial Source Hydrocolloids Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Microbial Source Hydrocolloids Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Microbial Source Hydrocolloids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CEAMSA
  2. 8.1.1 CEAMSA Company Information
  3. 8.1.2 CEAMSA Business Overview
  4. 8.1.3 CEAMSA Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CEAMSA Microbial Source Hydrocolloids Product Portfolio
  6. 8.1.5 CEAMSA Recent Developments
  7. 8.2 Hispanagar SA
  8. 8.2.1 Hispanagar SA Company Information
  9. 8.2.2 Hispanagar SA Business Overview
  10. 8.2.3 Hispanagar SA Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hispanagar SA Microbial Source Hydrocolloids Product Portfolio
  12. 8.2.5 Hispanagar SA Recent Developments
  13. 8.3 CP Kelco
  14. 8.3.1 CP Kelco Company Information
  15. 8.3.2 CP Kelco Business Overview
  16. 8.3.3 CP Kelco Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CP Kelco Microbial Source Hydrocolloids Product Portfolio
  18. 8.3.5 CP Kelco Recent Developments
  19. 8.4 DuPont
  20. 8.4.1 DuPont Company Information
  21. 8.4.2 DuPont Business Overview
  22. 8.4.3 DuPont Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DuPont Microbial Source Hydrocolloids Product Portfolio
  24. 8.4.5 DuPont Recent Developments
  25. 8.5 Cargill
  26. 8.5.1 Cargill Company Information
  27. 8.5.2 Cargill Business Overview
  28. 8.5.3 Cargill Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cargill Microbial Source Hydrocolloids Product Portfolio
  30. 8.5.5 Cargill Recent Developments
  31. 8.6 Ingredion
  32. 8.6.1 Ingredion Company Information
  33. 8.6.2 Ingredion Business Overview
  34. 8.6.3 Ingredion Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ingredion Microbial Source Hydrocolloids Product Portfolio
  36. 8.6.5 Ingredion Recent Developments
  37. 8.7 Archer Daniels Midland
  38. 8.7.1 Archer Daniels Midland Company Information
  39. 8.7.2 Archer Daniels Midland Business Overview
  40. 8.7.3 Archer Daniels Midland Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Archer Daniels Midland Microbial Source Hydrocolloids Product Portfolio
  42. 8.7.5 Archer Daniels Midland Recent Developments
  43. 8.8 Koninklijke DSM
  44. 8.8.1 Koninklijke DSM Company Information
  45. 8.8.2 Koninklijke DSM Business Overview
  46. 8.8.3 Koninklijke DSM Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Koninklijke DSM Microbial Source Hydrocolloids Product Portfolio
  48. 8.8.5 Koninklijke DSM Recent Developments
  49. 8.9 Ashland
  50. 8.9.1 Ashland Company Information
  51. 8.9.2 Ashland Business Overview
  52. 8.9.3 Ashland Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ashland Microbial Source Hydrocolloids Product Portfolio
  54. 8.9.5 Ashland Recent Developments
  55. 8.10 Fuerst Day Lawson
  56. 8.10.1 Fuerst Day Lawson Company Information
  57. 8.10.2 Fuerst Day Lawson Business Overview
  58. 8.10.3 Fuerst Day Lawson Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Fuerst Day Lawson Microbial Source Hydrocolloids Product Portfolio
  60. 8.10.5 Fuerst Day Lawson Recent Developments
  61. 8.11 Nestle
  62. 8.11.1 Nestle Company Information
  63. 8.11.2 Nestle Business Overview
  64. 8.11.3 Nestle Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nestle Microbial Source Hydrocolloids Product Portfolio
  66. 8.11.5 Nestle Recent Developments
  67. 8.12 Jungbunzlauer
  68. 8.12.1 Jungbunzlauer Company Information
  69. 8.12.2 Jungbunzlauer Business Overview
  70. 8.12.3 Jungbunzlauer Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jungbunzlauer Microbial Source Hydrocolloids Product Portfolio
  72. 8.12.5 Jungbunzlauer Recent Developments
  73. 8.13 Deosen Biochemical
  74. 8.13.1 Deosen Biochemical Company Information
  75. 8.13.2 Deosen Biochemical Business Overview
  76. 8.13.3 Deosen Biochemical Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Deosen Biochemical Microbial Source Hydrocolloids Product Portfolio
  78. 8.13.5 Deosen Biochemical Recent Developments
  79. 8.14 Tate & Lyle
  80. 8.14.1 Tate & Lyle Company Information
  81. 8.14.2 Tate & Lyle Business Overview
  82. 8.14.3 Tate & Lyle Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Tate & Lyle Microbial Source Hydrocolloids Product Portfolio
  84. 8.14.5 Tate & Lyle Recent Developments
  85. 8.15 Lubrizol
  86. 8.15.1 Lubrizol Company Information
  87. 8.15.2 Lubrizol Business Overview
  88. 8.15.3 Lubrizol Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Lubrizol Microbial Source Hydrocolloids Product Portfolio
  90. 8.15.5 Lubrizol Recent Developments
  91. 8.16 Fiberstar
  92. 8.16.1 Fiberstar Company Information
  93. 8.16.2 Fiberstar Business Overview
  94. 8.16.3 Fiberstar Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Fiberstar Microbial Source Hydrocolloids Product Portfolio
  96. 8.16.5 Fiberstar Recent Developments
  97. 8.17 B&V SRL
  98. 8.17.1 B&V SRL Company Information
  99. 8.17.2 B&V SRL Business Overview
  100. 8.17.3 B&V SRL Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 B&V SRL Microbial Source Hydrocolloids Product Portfolio
  102. 8.17.5 B&V SRL Recent Developments
  103. 8.18 Hawkins Watts
  104. 8.18.1 Hawkins Watts Company Information
  105. 8.18.2 Hawkins Watts Business Overview
  106. 8.18.3 Hawkins Watts Microbial Source Hydrocolloids Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Hawkins Watts Microbial Source Hydrocolloids Product Portfolio
  108. 8.18.5 Hawkins Watts Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Microbial Source Hydrocolloids Value Chain Analysis
  2. 9.1.1 Microbial Source Hydrocolloids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Microbial Source Hydrocolloids Production Mode & Process
  6. 9.2 Microbial Source Hydrocolloids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Microbial Source Hydrocolloids Distributors
  9. 9.2.3 Microbial Source Hydrocolloids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst